I have not expected any news yesterday knowing that to divulge info not via an official PR is not being done, not by Prof Arnon that is.
My expectations were high due to the large audience it attracted as well as analysts.
As you know, at the moment the company is hardly noticed, and well under the radar, unlike many other small bios who create a lot of noise over nothing.
Prof Arnon is a well spoken knowledgeable scientist, with Copaxone in her credit, if she is optimistic, as was yesterday, so am I, and with sufficient proof as of the present I am holding strong and long.
The chart clearly shows that the 'conversation' had an immediate positive impact on px.
So, a short reply to your question: No specific points of interest.